Clinical trials · California
Diffuse Midline Glioma, H3 K27M-Mutant clinical trials in California
We’re tracking 3 recruiting diffuse midline glioma, h3 k27m-mutant studies with a site in California — including Phase 1, Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies in California
- NCT04943848RecruitingPhase 1
Vaccine plus immune treatment for newly diagnosed brain stem tumors
This early-phase trial tests a customized vaccine (made from your tumor’s cell parts) along with an immune “checkpoint blocker” medicine. It’s for newly diagnosed DIPG/DMG to see if this combination is safe and can help control the cancer.
Orange, CaliforniaAges 1–18 - NCT05009992RecruitingPhase 2
Drug combination for diffuse midline gliomas in children and young adults
This Phase 2 trial studies whether a combination of medicines (including ONC201/related study drugs) can better treat diffuse midline gliomas, a type of brain/spinal cord tumor that often affects the midline. You may qualify if your tumor diagnosis is confirmed and your treatment timing (before radiation, after radiation, or at recurrence) matches one of the study groups.
San Diego, CaliforniaAges 2–39 - NCT05099003RecruitingPhase 1/Phase 2
Selinexor plus radiation for newly diagnosed brain tumors
This trial studies whether adding selinexor to standard radiation can improve outcomes for children and young teens with certain newly diagnosed high-grade brain tumors (including DIPG). It’s designed for specific tumor types and genetic markers, and people must be able to start treatment soon after diagnosis.
Loma Linda, CaliforniaAges 1–21
Where these studies are running in California
Institutions with a site for the recruiting diffuse midline glioma, h3 k27m-mutant studies listed above.
- Children's Hospital Los Angeles · 2 studies
- Rady Children's Hospital San Diego · 2 studies
- University of California, San Francisco · 2 studies
- Cedars-Sinai Medical Center
- Children's Hospital of Orange County
- CHOC Children's Hospital
- Kaiser Permanente-Oakland
- Loma Linda University Medical Center
What taking part in a diffuse midline glioma, h3 k27m-mutant study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Diffuse Midline Glioma, H3 K27M-Mutant trials in other states
Common questions
- Are there diffuse midline glioma, h3 k27m-mutant clinical trials in California?
- Yes. We're currently tracking 3 recruiting diffuse midline glioma, h3 k27m-mutant studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a diffuse midline glioma, h3 k27m-mutant study in California?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in California to take part?
- Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a diffuse midline glioma, h3 k27m-mutant trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New diffuse midline glioma, h3 k27m-mutant studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.